Likelihood of malignancy did not differ between boys and girls.
Sonographic characteristics associated with malignant thyroid nodules in children included solitary nodules, larger nodule size, and solid parenchyma, taller-than-wide shape, among others, according to a study published in the journal Radiology.
Researchers from Brigham and Women’s Hospital and Boston Children’s Hospital in Massachusetts sought to determine the relationship between demographic and sonographic characteristics of thyroid nodules and malignancy in a pediatric population. The researchers obtained data from 314 patients, mean age 14.9 years, who underwent US-guided fine-needle aspiration biopsy for a total of 404 nodules. Eighty-two percent of the patients were female.
The results showed that 77 nodules (19.1 percent) were malignant, and 68 (88.3 percent) of these were papillary thyroid carcinoma. Sonographic characteristics associated with malignant nodules included:
• Larger size
• Solid parenchyma
• Taller-than-wide shape
• Presence of speckled calcifications
• Lack of a smooth margin
• Presence of abnormal lymph nodes
The researchers did not find that the likelihood of malignancy differed between boys and girls (27.8 percent versus 22.7 percent.) There was also no difference in likelihood between prepubertal and pubertal patients (18.8 percent versus 19.1 percent, respectively). The cancer rate in patients with a solitary nodule was higher than that in patients with multiple nodules (29.4 percent versus 14.2 percent, respectively).
Interobserver variability for assessment of sonographic characteristics ranged from moderate to very strong.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Week, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.